---
layout: archive
title: "Recent Publications"
permalink: /publications/
author_profile: true
---



1.	Zhou Y#, Zhang Y#, Li M#, Ming T#, Zhang C, Huang C, Li J, Li F, Li H, Zhao E, Shu F, Liu L, Pan X, Gao Y, Tian L, Song L* *,Huang H**, __Liao W*__. Sci Immunol. 2024 Oct 4;9(100):eado8758.


2. Li J, Lan Z,<strong>Liao W</strong>, Horner JW, Xu X, Liu J, Yoshihama Y, Jiang S, Shim HS, Slotnik M, LaBella KA, Wu CJ, Dunner K, Jr., Hsu WH, Lee R, Khanduri I, Terranova C, Akdemir K, Chakravarti D, Shang X, Spring DJ, Wang YA, DePinho RA. Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature, 2023; 619, 632-639.


3. Lina Zhu#, Chengmei Huang#, Chao Zhang#, Enen Zhao, Yaxin Zhang, Xingyan Pan, Huilin Huang*, <strong>Liao W*</strong> , Xin Wang*. LncRNA MIR200CHG inhibits epithelial-mesenchymal transition in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nat Commun, 2023; 14: 8141.


4. Li M#, Huang C#, Wu Y#, Zhu L, Zhang Y, Zhou Y, Li H, Liu Z, Pan X, Wang X, Qiu J*, Li F*, <strong>Liao W*</strong>. Long non-coding RNA CCL14-AS suppresses invasiveness and lymph node metastasis of colorectal cancer cells by regulating MEP1A. Cancer Cell Int, 2023 Feb 15;23(1):27-42.



5. Dongni Shi#, Xianqiu Wu#, Yunting Jian#, Junye Wang#, Chengmei Huang, Shuang Mo, Yue Li, Fengtian Li, Chao Zhang, Dongsheng Zhang, Huizhong Zhang, Huilin Huang, Xin Chen, Y. Alan Wang, Chuyong Lin, Guozhen Liu*,Libing Song*, <strong>Wenting Liao*</strong>. Nat Commun. 2022 Sep 26;13(1):5644. doi: 10.1038/s41467-022-33285-x.


6. Huang C#, Ou R#, Chen X#, Zhang Y, Li J, Liang Y, Zhu X, Liu L, Li M, Lin D, Qiu J, Liu G, Zhang L, Wu Y, Tang H, Liu Y, Liang L, Ding Y*, <strong>Liao W*</strong>. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. J Exp Clin Cancer Res. 2021 Sep 28;40(1):304.


7. Wang S#, Qiu J#, Liu L#, Su C, Qi L, Huang C, Chen X, Zhang Y, Ye Y, Ding Y, Liang L*, <strong>Liao W*</strong>. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. J Exp Clin Cancer Res. 2020 Aug 25;39(1):168.


8. Zhu X#, Wang F#, Wu X, Li Z, Wang Z, Ren X, Zhou Y, Song F, Liang Y, Zeng Z, Liao W, Ding Y*,<strong>Liao W*</strong>, 
 Liang L*. FBX8 promotes metastatic dormancy of colorectal cancer in liver. Cell Death Dis. 2020 Aug 14;11(8):622.


9. <strong>Liao W</strong>, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, Li J, Wang G, Lan Z, Li J, Tang M, Jiang S, Ma X, Chen P, Katkhuda R, Korphaisarn K, Chakravarti D, Chang A, Spring DJ, Chang Q, Zhang J, Maru DM, Maeda DY, Zebala JA, Kopetz S, Wang YA*, DePinho RA*. KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell, 2019 Apr 15;35(4):559-572.


